Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 4, 2009

Max Planck Institute Places $426K Order with Geneart for Genes and Gene Variants

  • Max Planck Institute for Molecular Genetics awarded Geneart a contract to produce genes and gene variants for the project “Mutanom - Systems Biology of Genetic Diseases.” Genes will be developed over the next two years, and the expected order volume will be approximately €300,000, or slightly over $426,000.

    The Mutanom project’s goal is to research the effects of mutations in the genome and their relevance for genetic diseases. The project is funded by the Federal Ministry of Education and Research.



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »